Category: St. Jude Medical
Here's a look at some of the top legal news stories for medical device companies this week: Justice Dept. probes St. Jude for potential False Claims, kickbacks violations; More secret human studies uncovered in Myxo ring inquiry; Medtech manufacturer fleeced Stryker, says former exec; FDA morcellator warning spurs lawsuit against J&J; NuVasive claims win in patent spat with Cadwell Labs
, Dept. of Justice (DOJ)
, Edwards Lifesciences
, Ethicon Endo-Surgery
, Ferry Machine Corp.
, Food & Drug Administration (FDA)
, Johnson & Johnson
, St. Jude Medical
, Stryker Corp.
, U.S. Senate
The battle over battery life was a big part of this year's Heart Rhythm Society conference, but who came out on top?
A string of presentations and poster sessions during this week's Heart Rhythm conference pitted device makers against each other in the battle for battery superiority.
St. Jude Medical's game-changing Nanostim pacemaker still looks strong in 1-year results from an early study of heart failure patients.
A mega-study of cardiac implants suggests that remote monitoring may help cut mortality rates in half for the most engaged patients, but the reasons why are unclear.
Remotely monitored pacemaker patients devices may get a major leg up over patients without the extra surveillance, researchers reported today during Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions in San Francisco.
Medtronic's CRT-Ds were most likely to fail 1st in a pair of head-to-head studies comparing the devices to rival implants from Boston Scientific, Biotronik and St. Jude Medical.
Researchers say that devices used to close off the heart's left atrial appendage appear as good as anti-coagulation drugs for treating certain patients with an increased risk of having a stroke.
New clinical data continues to suggest that left atrial appendage occlusion devices may pose an improvement over warfarin drug regimens for treating patients at increased risk of stroke, researchers reported today.
St. Jude Medical's quadripolar pacing leads show better survival rates in the 1st head-to-head study comparing them to bipolar leads, researchers say.